N/A
N=1,100
Conducting Outreach to Improve Cervical Cancer Screening Rates Among Underscreened Patients
Uterine Cervical Neoplasms
Bottom Line
View on ClinicalTrials.gov: NCT02427399 ↗Enrolled (actual)
1,100
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Proportion of Patients Who Receive a Pap Test at End of Follow up — 44; 50; 53; 59 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Letter and informational sheet (Other); Email (Other); Phone (Other); Multimodal (Other)
- Age
- Adult · 21+ yrs
- Sex
- Female
- Sponsor
- Fenway Community Health
- Primary completion
- Dec 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Proportion of Patients Who Receive a Pap Test at End of Follow up |
44; 50; 53; 59; 74 | — |
| SECONDARY Proportion Receiving Pap Test at 6 Months |
15; 32; 24; 43; 53 | — |
| SECONDARY Proportion Receiving Pap Test at 12 Months |
34; 42; 45; 53; 70 | — |
Summary
The purpose of this project is to determine whether outreach to HIV-negative patients who are overdue for a Pap smear at a New England urban community health center can increase cervical cancer screening rates. It additionally seeks to determine which form of outreach - via letter, email, phone, or a mixture of those modalities- is most effective among these patients.
Eligibility Criteria
Inclusion Criteria
- Female or female-to-male transgender patients with a cervix
- HIV-negative
- Medical appointment at Fenway Community Health during calendar year 2012 who have not had a Pap smear in the past 3 years (since January 2010)
Exclusion Criteria
- HIV-positive (due to different Pap testing guidelines)
- Male-to-female transgender patients
- Patients with a history of a hysterectomy, unless specified as partial or supracervical
- Patients aged 30-64 who had a negative Pap test in the past 5 years with simultaneous negative Human papillomavirus infection (HPV) co-testing
Data sourced from ClinicalTrials.gov (NCT02427399). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.